Every imported question, contribution and motion, with its classification. Unflagged, uncertain and not-yet-analysed records are all included so the analysis can be checked independently.
To ask the First Minister and deputy First Minister whether they have (i) had; and (ii) requested, any meetings or briefings in relation to the Irish Presidency of the European Union.
To ask the Minister of Justice to detail (i) the number of Freedom of Information requests that are currently awaiting a response from her Department; and (ii) the number of those requests that have been outstanding for more than 20 working days.
To ask the Minister of Justice to detail (i) any assessment her Department has made of the statistically significant increase in those considering organised crime to be very or fairly widespread in their local area; and (ii) any plans her Department has to address this perception.
To ask the Minister of Justice to detail any strategic steps that her Department and the PSNI are taking to actively rebuild public trust and confidence in policing within protestant, unionist and loyalist communities.
To ask the Minister of Health to detail any data that is collected in relation to stroke patients, broken down by (i) age groups; and (ii) Section 75 characteristics.
To ask the Minister of Health to detail the process for (i) a legal advocacy; and (ii) legal support, under the Chronically Sick and Disabled Persons (Northern Ireland) Act 1978.
To ask the Minister of Health to detail (i) the current target turnaround times for histopathology results; (ii) how the current turnaround times compare with the targets in each Health and Social Care Trust; (iii) the current levels of any delay and backlog, including any action being taken to address these delays…
To ask the Minister of Health, pursuant to AQW 45391/22-27, whether his Department will lead a cross-departmental scoping exercise on establishing minimum safeguarding standards for organisations working with children that are not subject to statutory regulation.
To ask the Minister of Health, pursuant to AQW 45391/22-27, to detail the timetable for completing his Department’s work on options for introducing a wider legal duty to carry out checks on people seeking to work with children or adults at risk.
To ask the Minister of Health to detail (i) the number of Freedom of Information requests that are currently awaiting a response from his Department; and (ii) the number of those requests that have been outstanding for more than 20 working days.
To ask the Minister of Health, pursuant to AQW 52302/22-27, to detail further information on his officials' work on a small number of shortlisted options to inform future decisions on ADHD support, including what that entails.
To ask the Minister of Health to detail any assessment his Department has made of the impact of the transfer of maternity services from Daisy Hill Hospital to Craigavon Area Hospital on the medical and surgical departments at Craigavon Area Hospital.
To ask the Minister of Health to detail any circumstance where an inpatient maternity service, with up to 1700 births a year, has been transferred from one hospital to another.
To ask the Minister of Health to detail (i) whether all patients diagnosed with Grade three and Grade four gliomas, routinely receive molecular profiling of their tumours; (ii) which molecular markers are currently tested for; and (iii) any steps that are being taken to ensure patients can access targeted treatments…
To ask the Minister of Health to detail (i) the number of patients in Northern Ireland that have been diagnosed with Grade three and Grade four isocitrate dehydrogenase-mutant gliomas, in each of the last five years; (ii) any assessment that has been made of the potential benefits of Vorasidenib for such patients; and…
To ask the Minister of Health to detail (i) whether Northern Ireland has a dedicated clinical lead for brain tumour research; and (ii) any actions that are being taken to increase brain tumour research activity.
To ask the Minister of Health to detail (i) the number of patients that have been referred to brain tumour clinical trials, outside the United Kingdom, in each of the last five years; and (iii) any consideration that has been given to establishing a mechanism to support eligible patients participating in overseas…